Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02631746
Title Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Montefiore Medical Center-Einstein Campus Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus Bronx New York 10467 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field